Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Heart Failure

cabergoline has been researched along with Heart Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C1
Hayashi, T; Higuchi, Y; Hirayama, A; Ichibori, Y; Iwai, S; Makino, N; Minamiguchi, H; Mitake, A; Mori, N; Shiba, M; Shibuya, Y1
Chang, TJ; Huang, TS; Kao, YH1
Hiramoto, T; Kikuchi, A; Onodera, J; Onoue, N; Oumi, M; Sato, T1
Cevik, C; Feray, H; Izgi, C; Mansuroglu, D; Nugent, K; Saltan, Y1
Brophy, JM; Dell'Aniello, S; Renoux, C; Suissa, S1

Other Studies

6 other study(ies) available for cabergoline and Heart Failure

ArticleYear
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left

2023
Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Adult; Cabergoline; Cardiomyopathies; Cesarean Section; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders

2023
Thyrotropin-secreting pituitary tumor presenting with congestive heart failure and good response to dopaminergic agonist cabergoline.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2013, Volume: 112, Issue:11

    Topics: Aged; Cabergoline; Dopamine Agonists; Ergolines; Follow-Up Studies; Heart Failure; Humans; Male; Pituitary Neoplasms; Thyrotropin

2013
[Two cases of patients with Parkinson's disease developing valvular heart disease while taking cabergoline].
    Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:7

    Topics: Aged; Antiparkinson Agents; Cabergoline; Ergolines; Fatal Outcome; Female; Heart Failure; Heart Valve Diseases; Humans; Parkinson Disease

2008
Severe tricuspid regurgitation in a patient receiving low-dose cabergoline for the treatment of acromegaly.
    The Journal of heart valve disease, 2010, Volume: 19, Issue:6

    Topics: Acromegaly; Cabergoline; Diuretics; Echocardiography, Doppler, Color; Ergolines; Female; Furosemide; Heart Failure; Hormone Antagonists; Humans; Middle Aged; Severity of Illness Index; Treatment Outcome; Tricuspid Valve Insufficiency

2010
Dopamine agonist use and the risk of heart failure.
    Pharmacoepidemiology and drug safety, 2012, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cabergoline; Case-Control Studies; Databases, Factual; Dopamine Agonists; Ergolines; Female; Heart Failure; Humans; Incidence; Logistic Models; Male; Middle Aged; Pramipexole; Risk; United Kingdom

2012